Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07402954 · ClinicalTrials.gov registry record · NA

Stimulation of External Carotid Artery Circulation

A NA study of Migraine, sponsored by The University of Texas Medical Branch, Galveston.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT07402954 is a NA study of Migraine that is actively recruiting participants, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 12 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07402954, a NA study of Migraine, is actively recruiting participants, sponsored by The University of Texas Medical Branch, Galveston.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This study is testing a new approach to help people with migraine headaches. Researchers want to find out if using electrical stimulation to affect blood flow in the external carotid artery is safe and practical for helping control headaches. The goal of the study is to determine whether this approach could improve headache symptoms and overall outcomes for people with migraines.

Conditions Studied

Interventions

  • DEVICE Cadwell Cascade 32 PRO

Study Locations (1)

Texas

  • University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2026-01-16
Est. Completion 2027-08
Phase NA

What the Registry Record Tells You About NCT07402954

The ClinicalTrials.gov registry entry for NCT07402954 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (97% lower). The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Cadwell Cascade 32 PRO is the first listed.

NCT07402954 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07402954 about?

NCT07402954 is a clinical study titled "Stimulation of External Carotid Artery Circulation". This study is testing a new approach to help people with migraine headaches. Researchers want to find out if using electrical stimulation to affect blood flow in the external carotid artery is safe and practical for helping control headaches. The goal of the study is to determine whether this appro...

What is the current status of trial NCT07402954?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2026-01-16. Estimated completion is 2027-08.

What conditions does trial NCT07402954 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT07402954?

The interventions under investigation include: Cadwell Cascade 32 PRO (DEVICE).

Who is sponsoring clinical trial NCT07402954?

This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07402954 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.